These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6697283)

  • 1. Serogroups and serotypes of pneumococci in Montreal: correlations with age, outcome and indications for vaccination.
    Lamothe F; Delage G; Laverdière M; Saint-Antoine P
    Can Med Assoc J; 1984 Mar; 130(6):737-40. PubMed ID: 6697283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disribution of Streptococcus pneumoniae serotypes and serogroups among patients with invasive pneumococcal diseases in the Czech Republic in 1996-2003: background data for vaccination strategy].
    Motlová J
    Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):3-10. PubMed ID: 15807381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inferring the potential success of pneumococcal vaccination in Italy: serotypes and antibiotic resistance of Streptococcus pneumoniae isolates from invasive diseases.
    Pantosti A; Boccia D; D'Ambrosio F; Recchia S; Orefici G; Moro ML; ;
    Microb Drug Resist; 2003; 9 Suppl 1():S61-8. PubMed ID: 14633369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.
    Hausdorff WP; Bryant J; Paradiso PR; Siber GR
    Clin Infect Dis; 2000 Jan; 30(1):100-21. PubMed ID: 10619740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine.
    Gonzalez BE; Hulten KG; Lamberth L; Kaplan SL; Mason EO;
    Pediatr Infect Dis J; 2006 Apr; 25(4):301-5. PubMed ID: 16567980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococci causing invasive disease in New Zealand, 1987-94: serogroup and serotype coverage and antibiotic resistances.
    Martin DR; Brett MS
    N Z Med J; 1996 Aug; 109(1027):288-90. PubMed ID: 8773670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal serotypes causing bacteremia and meningitis: relevance to composition of pneumococcal vaccine.
    Dixon JM; Lipinski AE
    Can Med Assoc J; 1981 Aug; 125(3):263-7. PubMed ID: 7272879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bacteremic pneumococcal pneumonia].
    Pineda Solas V; Pérez Benito A; Domingo Puiggros M; Larramona Carrera H; Segura Porta F; Fontanals Aymerich D
    An Esp Pediatr; 2002 Nov; 57(5):408-13. PubMed ID: 12467543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media.
    Joloba ML; Windau A; Bajaksouzian S; Appelbaum PC; Hausdorff WP; Jacobs MR
    Clin Infect Dis; 2001 Nov; 33(9):1489-94. PubMed ID: 11588694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotype distribution of Streptococcus pneumoniae in north-western Greece and implications for a vaccination programme.
    Levidiotou S; Vrioni G; Tzanakaki G; Pappa C; Gesouli H; Gartzonika C; Papamichail D; Kremastinou J
    FEMS Immunol Med Microbiol; 2006 Nov; 48(2):179-82. PubMed ID: 17064274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine.
    Aguiar SI; Serrano I; Pinto FR; Melo-Cristino J; Ramirez M;
    Clin Microbiol Infect; 2008 Sep; 14(9):835-43. PubMed ID: 18844684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003.
    Adegbola RA; Hill PC; Secka O; Ikumapayi UN; Lahai G; Greenwood BM; Corrah T
    Trop Med Int Health; 2006 Jul; 11(7):1128-35. PubMed ID: 16827713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.
    Hausdorff WP; Bryant J; Kloek C; Paradiso PR; Siber GR
    Clin Infect Dis; 2000 Jan; 30(1):122-40. PubMed ID: 10619741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.
    Byington CL; Samore MH; Stoddard GJ; Barlow S; Daly J; Korgenski K; Firth S; Glover D; Jensen J; Mason EO; Shutt CK; Pavia AT
    Clin Infect Dis; 2005 Jul; 41(1):21-9. PubMed ID: 15937758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT).
    Scheifele D; Halperin S; Pelletier L; Talbot J
    Clin Infect Dis; 2000 Jul; 31(1):58-64. PubMed ID: 10913397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy.
    Serrano I; Ramirez M; Melo-Cristino J;
    Clin Microbiol Infect; 2004 Jul; 10(7):652-6. PubMed ID: 15214879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive pneumococcal disease in England and Wales: vaccination implications.
    Sleeman K; Knox K; George R; Miller E; Waight P; Griffiths D; Efstratiou A; Broughton K; Mayon-White RT; Moxon ER; Crook DW; ;
    J Infect Dis; 2001 Jan; 183(2):239-246. PubMed ID: 11120930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.
    Motlova J; Benes C; Kriz P
    Epidemiol Infect; 2009 Apr; 137(4):562-9. PubMed ID: 18796171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotypes of Streptococcus pneumoniae isolated from blood and cerebrospinal fluid related to vaccine serotypes and to clinical characteristics.
    Berg S; Trollfors B; Persson E; Backhaus E; Larsson P; Ek E; Claesson BE; Jonsson L; Rådberg G; Johansson S; Ripa T; Kaltoft MS; Konradsen HB
    Scand J Infect Dis; 2006; 38(6-7):427-32. PubMed ID: 16798688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.